Tectonic Therapeutic logo
Tectonic Therapeutic
TECX | NASDAQ
Chart Builder DCF Calculator
$20.98
-$0.16 (-0.76%)
At close: Nov 16, 2026, 4:00 PM ET
$20.98
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Tectonic Therapeutic Company Profile

Company profile explained

Company Profile

Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.

Key Executives

Name Position
Alise S. Reicin President, Chief Executive Officer, Secretary & Director
Daniel Lochner Chief Financial Officer
Anthony Muslin Chief Development Officer
Geraldine Peters-Wiles Senior Vice President of Human Resources
John Diener Senior Vice President of Antibody Engineering & Protein Sciences
Marc Schwabish Chief Business Officer
Marcella K. Ruddy Chief Medical Officer
Mary West Senior Vice President of Clinical Development Operations
Peter McNamara Chief Scientific Officer
Washington Alves Senior Vice President of Technical Operations

Latest SEC Filings

Date Type Title
Oct 29, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 28, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Oct 02, 2026 4 Filing
Sep 29, 2026 8-K Current Report
Sep 08, 2026 4 Filing
Sep 08, 2026 4 Filing
View All SEC Filings ➞
Tectonic Therapeutic
Tectonic Therapeutic logo
Country United States
IPO Date Jun 21, 2018
Industry Biotechnology
Sector Healthcare
Employees 60
CEO Alise S. Reicin

Contact Details

490 Arsenal Way Watertown, Massachusetts 02472 United States

Stock Details

Ticker Symbol TECX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001681087
CUSIP Number 878972108
ISIN Number US8789721086
SIC Code 2836

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.